STH1 Antibody

What is STH1 and why are antibodies against it important for chromatin research?

STH1 (Snf Two Homolog 1) is the catalytic subunit of the RSC chromatin remodeling complex that plays essential roles in chromatin architecture modification and gene expression regulation. Antibodies against STH1 are valuable tools for studying chromatin dynamics because they enable researchers to track the localization and activity of this key remodeling factor.

Studies have demonstrated that STH1 is an essential gene in organisms like Candida albicans, where its depletion induces significant cellular abnormalities including pseudohyphal cells and abnormal spindle morphology . STH1 antibodies allow researchers to perform crucial experiments such as chromatin immunoprecipitation (ChIP) assays that reveal STH1's enrichment at centromeric chromatin regions, providing insights into its role in chromosome segregation .

How do I validate the specificity of an STH1 antibody for research applications?

Validating STH1 antibody specificity requires a multi-step approach to ensure reliable experimental results:

• Western blot analysis: Compare protein expression in wild-type cells versus STH1-depleted or knockout cells (if viable). A specific antibody will show significantly reduced signal in depleted samples.

• Immunofluorescence microscopy validation: STH1 should display nuclear localization throughout the cell cycle as demonstrated in previous studies. Compare this pattern with STH1-depleted cells where the signal should be significantly reduced .

• Chromatin immunoprecipitation controls: Include non-specific IgG controls and test enrichment at known binding sites (centromeres) versus non-binding genomic regions (certain arm regions) to confirm specificity .

• Epitope competition assays: Pre-incubate the antibody with purified STH1 protein or peptide before performing detection experiments. Signal reduction indicates specific binding.

• Cross-reactivity testing: Test the antibody against related chromatin remodelers to ensure it doesn't recognize similar proteins.

What experimental methods can detect STH1 localization in chromatin?

Several methods can effectively detect STH1 localization in chromatin:

• Chromatin Immunoprecipitation (ChIP): The gold standard for studying protein-DNA interactions. This method has successfully demonstrated STH1 binding to centromeres but not to non-centromeric chromosomal arm regions in organisms like C. albicans . The protocol typically involves:

  • Crosslinking proteins to DNA with formaldehyde

  • Sonicating chromatin to appropriate fragment sizes

  • Immunoprecipitating with STH1 antibody

  • Analyzing enriched DNA by qPCR or sequencing

• Immunofluorescence microscopy: Allows visualization of STH1 distribution within nuclei throughout the cell cycle. Studies have shown that STH1 localizes within the nucleus during all cell cycle phases .

• Chromatin fractionation followed by western blotting: This biochemical approach separates chromatin-bound from unbound proteins, allowing detection of STH1 in different nuclear compartments.

• CUT&RUN or CUT&Tag: These newer techniques offer higher resolution and lower background than traditional ChIP, requiring fewer cells for analysis of STH1 binding sites.

How can I use STH1 antibodies to study the relationship between chromatin remodeling and cell cycle progression?

STH1 antibodies provide valuable tools for investigating the relationship between chromatin remodeling and cell cycle progression through several methodological approaches:

• Synchronization experiments: Synchronize cells at different cell cycle stages and use STH1 antibodies to track changes in localization or activity through:

  • Western blotting of chromatin fractions

  • ChIP-qPCR at key genomic loci

  • Immunofluorescence microscopy

• Co-localization studies: Combine STH1 antibodies with antibodies against cell cycle markers to determine temporal relationships between STH1 activity and cell cycle transitions. Research has shown STH1 is present in the nucleus throughout the cell cycle .

• Conditional depletion systems: In systems where STH1 expression can be conditionally regulated (such as through repressible promoters like PCK1, MET3, or TET), monitor cell cycle phenotypes:

  • STH1 depletion causes accumulation of multibudded and elongated pseudohyphal cell populations (~26% after 12 hours of depletion)

  • Cell cycle arrest occurs at the G2/M phase when STH1 is depleted

  • Sensitivity to anti-microtubule drugs like thiabendazole (TBZ) increases in STH1-depleted cells

• Checkpoint activation analysis: STH1 depletion activates the spindle assembly checkpoint (SAC). This connection can be studied by combining STH1 depletion with SAC component deletions (e.g., MAD2 deletion), which relieves the cell cycle arrest phenotype .

How can I develop highly specific monoclonal antibodies against different epitopes of STH1?

Developing highly specific monoclonal antibodies against different STH1 epitopes requires strategic planning and advanced techniques:

• Epitope selection and design:

  • Analyze STH1 protein structure to identify unique, accessible domains

  • Use bioinformatics tools to predict antigenic regions that distinguish STH1 from related proteins

  • Consider generating antibodies against:

    • N-terminal domains

    • ATPase catalytic domain

    • Species-specific regions for cross-species studies

• High-throughput antibody generation strategies:

  • Utilize phage display technology for antibody selection, which can include:

    • Selection against specific complexes (as demonstrated in antibody selection protocols )

    • Multiple rounds of selection with amplification steps

    • Systematic collection of phages at each step to monitor library composition

  • Employ oligo pool synthesis for natively paired antibody libraries:

    • Split target sequences into overlapping oligos (~300-350 nucleotides)

    • Perform codon randomization to ensure unique overlaps at the nucleic acid level

    • Generate full-length sequences through one-pot overlap PCR

• Specificity screening and validation:

  • Screen antibody candidates against:

    • Wild-type STH1

    • STH1 mutants with altered domains

    • Related chromatin remodelers

  • Employ computational models to predict binding specificity:

    • Train models using selection experiment data

    • Parametrize energy functions using shallow dense neural networks

    • Optimize to capture antibody population evolution across experiments

• Custom specificity engineering:

  • Design antibodies with predefined binding profiles using computational models

  • For cross-specific antibodies: jointly minimize the energy functions associated with desired ligands

  • For highly specific antibodies: minimize energy functions for desired epitopes while maximizing for undesired targets

What are the most effective protocols for using STH1 antibodies to study global chromatin architecture changes?

Advanced protocols for using STH1 antibodies to study global chromatin architecture changes include:

• MNase sensitivity assays with immunoblotting:

  • Digest chromatin with micrococcal nuclease (MNase) for increasing time periods (0, 10, 20, 40 min)

  • Purify DNA and analyze on agarose gel with ethidium bromide staining

  • Compare nucleosome ladder patterns between wild-type and STH1-depleted cells

  • Note: STH1 depletion has been shown to dramatically alter global chromatin structure, with primarily mono- and di-nucleosomes visible compared to 8-9 nucleosome ladders in wild-type cells

• ChIP-seq with STH1 antibodies:

  • Perform chromatin immunoprecipitation with STH1 antibodies

  • Sequence precipitated DNA to generate genome-wide binding profiles

  • Compare binding patterns across different conditions (e.g., cell cycle stages, stress responses)

  • Analyze data using peak calling algorithms and correlation with known chromatin features

• Hi-C combined with STH1 perturbation:

  • Generate genome-wide chromatin interaction maps in STH1 wild-type and depleted conditions

  • Analyze changes in topologically associating domains (TADs) and chromatin loops

  • Correlate structural changes with STH1 binding sites identified by ChIP

• ATAC-seq analysis:

  • Compare chromatin accessibility in wild-type versus STH1-depleted cells

  • Identify regions where STH1 activity affects chromatin openness

  • Correlate with transcriptional changes and other genomic features

• Sequential ChIP (re-ChIP):

  • Use STH1 antibodies in combination with antibodies against other chromatin-associated factors

  • Identify genomic loci where STH1 co-occurs with specific histone modifications or other remodelers

  • This approach can reveal functional cooperation between different chromatin regulators

How can STH1 antibodies be used to investigate the mechanistic role of RSC in kinetochore function and chromosome segregation?

Advanced approaches to investigate RSC's role in kinetochore function and chromosome segregation using STH1 antibodies include:

• Combined immunofluorescence and live-cell imaging:

  • Use STH1 antibodies for immunofluorescence microscopy alongside kinetochore markers

  • Quantify kinetochore clustering in wild-type versus STH1-depleted cells

  • Research has demonstrated that STH1 depletion reduces kinetochore clustering from 1-2 foci per nucleus in wild-type cells to multiple dispersed foci in depleted cells

• ChIP-qPCR at centromeric regions:

  • Target centromeric regions and pericentromeric chromatin

  • Compare STH1 enrichment at centromeres versus arm regions

  • Studies show STH1 binds specifically to centromeres but not to non-centromeric chromosomal arm regions

• Analysis of cohesin recruitment:

  • Perform ChIP for cohesin components (e.g., Mcd1) in STH1 wild-type, depleted, and overexpressed conditions

  • Quantify cohesin association at centromeric and arm regions

  • Research shows reduction in Mcd1 association at centromeres in both STH1-depleted and overexpressed conditions, indicating a requirement for homeostasis of RSC activity

• Spindle assembly checkpoint activation studies:

  • Combine STH1 depletion with checkpoint component (e.g., Mad2) deletion

  • Monitor multibudded and elongated phenotypes

  • Research demonstrates that Mad2 removal relieves stress-induced phenotypes in STH1-depleted cells

• Chromatin conformation capture at centromeres:

  • Apply 3C or 4C techniques focusing on centromeric regions

  • Compare chromatin architecture in normal versus STH1-depleted conditions

  • Correlate with functional changes in kinetochore organization

What approaches can resolve contradictory data when STH1 antibodies show unexpected binding patterns?

When faced with contradictory or unexpected STH1 antibody binding patterns, several sophisticated approaches can help resolve these discrepancies:

• Antibody epitope mapping and competition assays:

  • Map the exact epitope recognized by the antibody using peptide arrays or hydrogen-deuterium exchange mass spectrometry

  • Perform competition assays with purified protein domains to determine if unexpected binding is due to epitope similarities

  • Use computational modeling to predict cross-reactivity based on structural similarities

• Validation across multiple antibody types:

  • Compare monoclonal versus polyclonal antibodies targeting different STH1 epitopes

  • Utilize antibodies from different host species to eliminate host-specific background

  • Apply high-throughput antibody characterization to identify the most specific candidates:

    • Employ mRNA display techniques for rapid specificity characterization

    • Screen against different epitopes and related proteins

• Genetic complementation with tagged STH1 variants:

  • Create cell lines expressing STH1 with different tags (FLAG, HA, GFP)

  • Compare antibody binding patterns with tag-specific antibody detection

  • Introduce mutations in potential cross-reactive epitopes to identify specificity determinants

• Multi-omics integration approach:

  • Combine ChIP-seq, RNA-seq, and proteomics data

  • Correlate STH1 binding with functional outcomes like transcriptional changes

  • Use network analysis to identify meaningful versus artifactual binding events

• Advanced negative controls and specificity tests:

  • Use CRISPR/Cas9 to create precise epitope modifications that disrupt antibody binding

  • Perform ChIP-exo or ChIP-nexus for higher resolution binding site identification

  • Apply sequential ChIP (re-ChIP) to confirm co-occupancy with known interacting partners

What are the optimal fixation and permeabilization conditions for STH1 antibody in immunofluorescence microscopy?

Optimizing fixation and permeabilization for STH1 immunofluorescence requires careful consideration of chromatin structure preservation:

• Fixation optimization:

  • Paraformaldehyde fixation (3-4%) for 15-20 minutes typically balances structure preservation with epitope accessibility

  • For dual fixation, combine with 0.05-0.1% glutaraldehyde to better preserve nuclear architecture

  • Methanol fixation (-20°C for 10 minutes) may provide superior nuclear protein detection in some cases

  • Cold ethanol fixation can be effective for detecting chromatin-bound proteins

• Permeabilization approaches:

  • Triton X-100 (0.1-0.5%) is commonly effective for nuclear proteins

  • Digitonin (10-50 μg/ml) offers gentler permeabilization that better preserves nuclear structure

  • For challenging epitopes, try saponin (0.025-0.1%) which creates smaller pores

  • Sequential permeabilization with different detergents may improve antibody accessibility

• Antigen retrieval techniques:

  • Heat-mediated antigen retrieval in citrate buffer (pH 6.0) can expose hidden epitopes

  • For chromatin-bound proteins like STH1, consider limited nuclease digestion to improve accessibility

  • Test epitope unmasking with 0.1% SDS treatment followed by thorough washing

• Protocol optimizations based on STH1 research:

  • Since STH1 has been successfully visualized within nuclei throughout the cell cycle , protocols preserving cell cycle stage indicators are important

  • Consider cell synchronization to compare STH1 localization across cell cycle stages

  • When studying kinetochore clustering, ensure fixation conditions preserve nuclear architecture

• Validated controls:

  • Include STH1-depleted cells as negative controls

  • Co-stain with nuclear envelope markers to define nuclear boundaries

  • Include known STH1 interactors (other RSC components) as positive controls

How can I optimize ChIP protocols for STH1 to study its binding to different chromatin regions?

Optimizing ChIP protocols for STH1 to study binding across diverse chromatin regions requires several specific considerations:

• Crosslinking optimization:

  • Standard formaldehyde (1%) for 10-15 minutes works for many chromatin proteins

  • For transient interactions, shorter crosslinking (5-10 minutes) may capture dynamic binding

  • Double crosslinking with DSG (disuccinimidyl glutarate) followed by formaldehyde can stabilize protein-protein interactions within complexes

  • Test crosslinking efficiency by monitoring STH1 shift to chromatin fraction via western blot

• Chromatin fragmentation strategies:

  • Sonication parameters should be carefully optimized (200-400bp fragments typically work well)

  • For centromeric regions, which are often repetitive and compact, more extensive sonication may be required

  • Enzymatic digestion with MNase can provide better resolution for nucleosome-level analysis

  • Consider using a combination of limited MNase digestion followed by sonication for difficult regions

• Antibody selection and validation:

  • Test multiple antibodies recognizing different STH1 epitopes

  • Validate antibody specificity with western blot and peptide competition

  • For each antibody, optimize antibody:chromatin ratio through titration experiments

  • Consider using tagged STH1 versions and corresponding tag antibodies as alternative approach

• Washing conditions and stringency:

  • Adjust salt concentration in wash buffers based on binding strength

  • Higher stringency washing (up to 500mM NaCl) reduces background but may eliminate weaker binding sites

  • Lower stringency may be needed to detect transient interactions

  • Consider a gradient of washing stringencies to characterize different binding affinities

• Region-specific optimizations:

  • For centromeres where STH1 is known to bind , include specific primers in qPCR validation

  • Since STH1 binding to arm regions may be weaker or more transient , more sensitive detection methods may be needed

  • Consider ChIP-exo or ChIP-nexus for higher resolution mapping of binding sites

  • For certain genome regions, spike-in normalization may improve quantification accuracy

What are the critical considerations when designing immunoprecipitation experiments to study STH1 interactions with other chromatin factors?

Designing effective immunoprecipitation (IP) experiments to study STH1 interactions requires consideration of multiple technical aspects:

• Extraction and buffer optimization:

  • Test different extraction conditions to maintain native interactions:

    • Low salt (150mM NaCl) preserves more interactions but increases background

    • Higher salt (300-400mM) increases stringency but may disrupt weaker interactions

    • Consider ionic strength, pH, and detergent type/concentration

  • Include appropriate protease and phosphatase inhibitors to preserve interaction states

  • Test benzonase treatment to determine if interactions are DNA-mediated

• IP approach selection:

  • Standard IP: Pull down with STH1 antibody and probe for interacting partners

  • Reverse IP: Pull down with antibodies against suspected interactors and probe for STH1

  • Sequential IP (re-IP): First IP with STH1 antibody, elute, then IP with antibody against interactor

  • For RSC complex components, consider both approaches to confirm interactions

• Controls and validation:

  • Include multiple negative controls:

    • IgG from same species as STH1 antibody

    • STH1-depleted extracts as negative control

    • Competition with epitope peptide

  • Validate interactions through reciprocal IPs

  • Consider proximity ligation assays (PLA) for in situ validation of interactions

• Analysis of specific interactions:

  • For studying cohesin interactions with STH1/RSC:

    • Design IPs to detect Mcd1 association with STH1

    • Compare results between wild-type, STH1-depleted, and overexpressed conditions

  • For kinetochore interactions:

    • Include kinetochore components in analysis

    • Correlate with functional studies of kinetochore clustering

• Advanced approaches:

  • BioID or APEX proximity labeling with STH1 fusion proteins to identify neighboring proteins

  • Crosslinking mass spectrometry (XL-MS) to map interaction interfaces

  • Size exclusion chromatography followed by western blotting to analyze complex integrity

How can computational approaches improve STH1 antibody design and epitope selection for specific research applications?

Advanced computational approaches can significantly enhance STH1 antibody design and epitope selection:

• Biophysics-informed modeling for antibody specificity:

  • Implement shallow dense neural networks to parametrize binding energy functions

  • Train models using experimental selection data to capture antibody population evolution

  • Employ these models to predict selection probabilities for antibody variants

  • Design custom binding profiles through energy function optimization:

    • For cross-specific antibodies: jointly minimize energy functions for desired ligands

    • For highly specific antibodies: minimize for desired targets while maximizing for undesired ones

• Structural biology approaches for epitope selection:

  • Analyze protein structure databases for STH1 or homologous proteins

  • Identify surface-exposed regions unique to STH1 versus other chromatin remodelers

  • Use molecular dynamics simulations to assess epitope flexibility and accessibility

  • Apply B-cell epitope prediction algorithms to identify likely antigenic regions

• Sequence-based approaches:

  • Perform multiple sequence alignment of STH1 across species to identify:

    • Conserved regions for broad cross-reactivity

    • Species-specific regions for selective targeting

  • Analyze protein domains to target functionally important regions:

    • ATP-binding domains

    • DNA-binding regions

    • Protein-protein interaction interfaces

• Integration with experimental data:

  • Use published ChIP-seq data to identify accessible regions of STH1 in its native context

  • Analyze post-translational modification patterns to avoid modified epitopes that might affect antibody recognition

  • Incorporate hydrogen-deuterium exchange mass spectrometry data to identify solvent-accessible regions

• High-throughput design-test cycles:

  • Design oligo pools for native antibody pairing using sequence-splitting strategies :

    • Split sequences into ~300-350 nucleotide oligos

    • Create overlaps at diverse complementary-determining regions (CDRs)

    • Perform codon randomization to ensure unique overlaps at nucleic acid level

  • Use machine learning to predict binding properties before synthesis

  • Implement rapid characterization through mRNA display techniques

How are STH1 antibodies being used to investigate the relationship between chromatin remodeling and disease states?

STH1 antibodies are increasingly valuable for investigating connections between chromatin remodeling dysregulation and disease:

• Cancer research applications:

  • Chromatin remodeling complexes like RSC/SWI/SNF are frequently mutated in cancers

  • STH1 antibodies can help characterize:

    • Altered binding patterns in cancer cells

    • Changes in global chromatin structure

    • Disrupted regulatory pathways due to RSC dysfunction

  • Compare STH1 chromatin occupancy in normal versus cancer cells using ChIP-seq

• Fungal pathogenesis studies:

  • Since STH1 is essential in fungal pathogens like C. albicans , antibodies enable:

    • Investigation of chromatin-based virulence mechanisms

    • Study of cell cycle regulation in pathogenic states

    • Exploration of STH1 as a potential antifungal target

  • Research has shown STH1 depletion induces pseudohyphal cells and abnormal spindle morphology in C. albicans

• Developmental disorders:

  • Chromatin remodeling defects are implicated in neurodevelopmental conditions

  • STH1 antibodies can help examine:

    • Cell-type specific chromatin patterns during development

    • Disruption of developmental timing due to remodeling defects

    • Changes in gene expression programs in model systems

• Aging research:

  • Chromatin architecture changes during aging

  • STH1 antibodies allow investigation of:

    • Age-related changes in RSC complex distribution

    • Altered nucleosome positioning associated with aging

    • Connections between replication stress, genome instability, and RSC function

• Drug discovery applications:

  • STH1 antibodies can facilitate:

    • High-throughput screening for compounds affecting RSC function

    • Target validation studies for chromatin-targeted therapeutics

    • Biomarker development for treatment response

What novel techniques are emerging for studying STH1 dynamics in live cells?

Emerging technologies are expanding capabilities for studying STH1 dynamics in living systems:

• Antibody-derived live-cell imaging approaches:

  • Single-chain variable fragments (scFvs) derived from STH1 antibodies can be:

    • Fused to fluorescent proteins for live imaging

    • Expressed as intrabodies for real-time tracking

    • Used in FRET-based sensors to detect conformational changes

  • These approaches overcome traditional limitations of antibodies in live cells

• CRISPR-based tracking systems:

  • CRISPR techniques for STH1 visualization include:

    • dCas9-GFP for tracking genomic loci where STH1 binds

    • STH1-Halo or SNAP tag fusions for pulse-chase dynamics

    • Dendra2 or other photoconvertible tag fusions for monitoring protein turnover

• Single-molecule approaches:

  • Advanced microscopy techniques allow:

    • Single-molecule tracking of labeled STH1 to measure diffusion rates

    • Residence time analysis at specific genomic loci

    • Counting absolute numbers of STH1 molecules per complex

  • These approaches reveal dynamics invisible to ensemble measurements

• Optogenetic control systems:

  • Light-inducible STH1 perturbation enables:

    • Precise temporal control of STH1 function

    • Spatial restriction of activity to specific cellular compartments

    • Direct observation of immediate consequences of STH1 inactivation

  • These systems complement traditional genetic approaches with improved resolution

• Biosensor development:

  • Novel biosensors to monitor STH1 activity include:

    • FRET-based sensors reporting on ATP hydrolysis

    • Conformation-sensitive probes detecting STH1 structural changes

    • Chromatin sensors reporting on local remodeling events

  • These tools bridge the gap between biochemical and cellular studies

How can multi-omics approaches incorporating STH1 antibodies provide insights into chromatin regulation mechanisms?

Integrative multi-omics approaches with STH1 antibodies enable comprehensive understanding of chromatin regulation:

• ChIP-seq integrated with other genomic methods:

  • Combine STH1 ChIP-seq with:

    • ATAC-seq to correlate binding with chromatin accessibility changes

    • RNA-seq to link remodeling to transcriptional outcomes

    • Hi-C to connect binding to 3D genome organization

  • Integration reveals functional consequences of STH1-mediated remodeling

• Proteomics integration approaches:

  • Couple STH1 immunoprecipitation with mass spectrometry to identify:

    • Cell-type or condition-specific interaction partners

    • Post-translational modifications regulating STH1 function

    • Changes in complex composition under different conditions

  • Correlation with ChIP-seq data links protein interactions to genomic locations

• Single-cell multi-omics with STH1 antibodies:

  • Apply STH1 antibodies in techniques like:

    • scCUT&Tag for single-cell profiling of STH1 binding

    • Simultaneous scRNA-seq and scATAC-seq to correlate with gene expression

    • Spatial transcriptomics combined with STH1 immunofluorescence

  • These approaches reveal cell-to-cell heterogeneity in STH1 function

• Time-resolved multi-omics:

  • Sequential sampling approaches to track dynamics:

    • ChIP-seq at multiple timepoints after perturbation

    • Pulse-chase protein labeling combined with IP-MS

    • Live-cell imaging followed by fixed-cell sequencing (MOVIE-seq)

  • These methods connect immediate STH1 binding changes to downstream effects

• Computational integration frameworks:

  • Machine learning approaches to integrate multi-omics STH1 data:

    • Predict functional outcomes of binding events

    • Identify key regulatory nodes in chromatin networks

    • Model causal relationships between remodeling and gene expression

  • Network analysis to place STH1 in broader regulatory contexts

What are the future directions for STH1 antibody development and application in chromatin biology?

The future of STH1 antibody development and application in chromatin biology research holds several promising directions:

• Next-generation antibody technologies:

  • Development of recombinant antibodies with precisely engineered properties

  • Creation of bispecific antibodies targeting STH1 alongside interacting partners

  • Application of synthetic nanobodies with enhanced tissue penetration

  • Integration of computational design methods for custom specificity profiles

• Expanded application in disease models:

  • Characterization of RSC complex dysfunction in cancer and developmental disorders

  • Development of STH1-targeted diagnostics for chromatin remodeling defects

  • Investigation of therapeutic approaches targeting RSC complex activity

  • Analysis of STH1 function in aging and age-related diseases

• Single-molecule and single-cell resolution studies:

  • Implementation of super-resolution microscopy with highly specific antibodies

  • Development of single-cell chromatin profiling methods incorporating STH1 targeting

  • Real-time tracking of STH1 dynamics during cell cycle progression and differentiation

  • Spatial transcriptomics integration to map STH1 activity in tissue contexts

• Multi-modal chromatin analysis:

  • Combining STH1 binding data with nucleosome positioning, histone modifications, and 3D organization

  • Integrating functional genomics approaches to link chromatin structure to cellular phenotypes

  • Developing comprehensive models of chromatin regulation incorporating RSC activity

  • Mapping the interplay between different remodeling complexes across the genome

• Methodological innovations:

  • Optimized high-throughput antibody screening through oligo pool synthesis

  • Advanced epitope mapping to enhance specificity and reduce cross-reactivity

  • Novel fixation and extraction protocols to preserve native chromatin states

  • Expansion of computational tools for predicting and designing antibody properties